Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
ABSTRACTCheckpoint blockade immunotherapy transforms many types of cancer; however, in the field of metastatic colorectal cancer, checkpoint blockers are only effective in microsatellite-unstable tumors, which represent only a minority of patients. Microsatellite-stable tumors are thought to be immu...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2257098 |
_version_ | 1797367163047116800 |
---|---|
author | Marion Thibaudin Francois Ghiringhelli |
author_facet | Marion Thibaudin Francois Ghiringhelli |
author_sort | Marion Thibaudin |
collection | DOAJ |
description | ABSTRACTCheckpoint blockade immunotherapy transforms many types of cancer; however, in the field of metastatic colorectal cancer, checkpoint blockers are only effective in microsatellite-unstable tumors, which represent only a minority of patients. Microsatellite-stable tumors are thought to be immunoresistant. A recent publication demonstrates that, contrary to the standard view point, the combination of chemo-immunotherapy could trigger a tumor-specific immune response, leading to clinical benefit. |
first_indexed | 2024-03-08T17:13:25Z |
format | Article |
id | doaj.art-f451b3f0b7a7407097944215a0f8019d |
institution | Directory Open Access Journal |
issn | 2162-402X |
language | English |
last_indexed | 2024-03-08T17:13:25Z |
publishDate | 2023-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | OncoImmunology |
spelling | doaj.art-f451b3f0b7a7407097944215a0f8019d2024-01-03T19:25:37ZengTaylor & Francis GroupOncoImmunology2162-402X2023-12-0112110.1080/2162402X.2023.2257098Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancerMarion Thibaudin0Francois Ghiringhelli1University of Bourgogne, Dijon, FranceUniversity of Bourgogne, Dijon, FranceABSTRACTCheckpoint blockade immunotherapy transforms many types of cancer; however, in the field of metastatic colorectal cancer, checkpoint blockers are only effective in microsatellite-unstable tumors, which represent only a minority of patients. Microsatellite-stable tumors are thought to be immunoresistant. A recent publication demonstrates that, contrary to the standard view point, the combination of chemo-immunotherapy could trigger a tumor-specific immune response, leading to clinical benefit.https://www.tandfonline.com/doi/10.1080/2162402X.2023.2257098Checkpoint blockadeclinical trialcolorectal cancerimmunogenic cell death |
spellingShingle | Marion Thibaudin Francois Ghiringhelli Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer OncoImmunology Checkpoint blockade clinical trial colorectal cancer immunogenic cell death |
title | Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer |
title_full | Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer |
title_fullStr | Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer |
title_full_unstemmed | Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer |
title_short | Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer |
title_sort | chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer |
topic | Checkpoint blockade clinical trial colorectal cancer immunogenic cell death |
url | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2257098 |
work_keys_str_mv | AT marionthibaudin chemoimmunotherapytriggersimmuneresponsestargetingmicrosatellitestablecolorectalcancer AT francoisghiringhelli chemoimmunotherapytriggersimmuneresponsestargetingmicrosatellitestablecolorectalcancer |